ライフサイエンスコーパス: composite tissue allograft

1 ntribution of the bone marrow component in a composite tissue allograft.

2 80% of her face was replaced with a tailored composite tissue allograft.

3 rance in the recipients of the rat hind limb composite tissue allografts.

4 nce could be generated in miniature swine to composite tissue allografts across a major histocompatib

5 tolerance to the musculoskeletal elements of composite tissue allografts across an MHC barrier in min

6 himerism induces donor-specific tolerance to composite tissue allografts across major histocompatibil

7 Composite tissue allografts are made of histogenetically

8 07 Working Classification of Skin-Containing Composite Tissue Allograft, but the role of early vascul

9 herapy has been found to effectively prevent composite tissue allograft (CTA) rejection with minimal

10 Although prolonged composite tissue allograft (CTA) survival is achievable

11 ole of host thymus in tolerance induction in composite tissue allografts (CTA) across major histocomp

12 cyclosporine A (CsA) can extend survival in composite tissue allografts (CTA).

13 (MAC) has been shown to induce tolerance to composite tissue allografts (CTA).

14 the role of Treg in peripheral tolerance to composite tissue allografts (CTA).

15 Transplantation of composite-tissue allograft (CTA) such as the human hand

16 ne A (CsA) to induce tolerance for hind limb composite tissue allograft in rats without chronic immun

17 fforts have been made to induce tolerance to composite tissue allografts in adult recipients, thus fa

18 t that the vascularized bone marrow within a composite tissue allograft is not the component that cau

19 large volume of vascularized bone marrow in composite tissue allografts may be a risk factor for PTL

20 nimals and humans and suggests that although composite tissue allografts may have a significant skin

21 Tolerance to composite tissue allografts might allow the widespread c

22 n be significantly delayed in a large-animal composite tissue allograft model including skin using on

23 ation, we developed a large-animal extremity composite tissue allograft model to assess the antirejec

24 Composite tissue allografts offer great potential in rec

25 complex craniofacial defects, application of composite tissue allografts opens unique one-stage recon

26 The clinical application of composite tissue allograft transplants opened the discus

27 of donor-specific tolerance in rat hind-limb composite tissue allografts using a alphabeta-TCR/CsA pr

28 r diagnosing acute rejection in vascularized composite tissue allograft (VCA) have been established b

29 Vascularized composite tissue allografts (VCA) can undergo rejection,

30 Vascularized composite tissue allografts (VCA) have become a viable o

31 lantation and immunosuppressive regimen, the composite tissue allograft with vascularized bone marrow